+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID07545902

Study of PROXERA PSOMED 20 Cream and PROXERA PSOMED 40 Gel for Treating Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis in Adults

Led by ICIM International S.r.l. · Updated on 2026-07-28

35

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of two CE-marked topical medical devices, PROXERA PSOMED 20 and PROXERA PSOMED 40, in people with different types of psoriasis. PROXERA PSOMED 20 is studied in participants with non-palmoplantar plaque psoriasis, while PROXERA PSOMED 40 is studied in those with non-pustular palmoplantar psoriasis. The goal is to see if applying these devices to a target area improves psoriasis compared to an untreated, similar area on the opposite side of the body. This is an interventional, single-center, randomized, single-blind study.

CONDITIONS

Brief Title

Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis

Research Team

P

Paolo Amerio, Professore Ordinario

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here